Parenteral Drugs Market By Product Type (Insulin, Monoclonal Antibodies, Cytokines, Peptide Hormones and Others), By Route of Administration (Subcutaneous, Intramuscular, Intravenous), By Application (Oncology, Diabetes, Cardiovascular Diseases, Blood Disorders and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, Retail Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Parenteral Drugs Market is expected to reach US$ 1228 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.60% from its 2024 valuation of US$ 490.5 billion.

Parenteral drugs are those administered by injection through a route other than the digestive tract. Parenteral medications include insulin, opioid analgesics, vaccines, and antibiotics, to name a few.

The preference of patients for injections over oral medications has fueled market expansion. The market has grown as a result of the rising incidence of diseases, the efficiency of parenteral medications, and the quick relief they provide because they are injected directly into a vein in the bloodstream. Future growth prospects for the parenteral drugs market are anticipated to be highly lucrative, owing to the increasing number of drug approvals and growing strategic partnerships among companies.